Conmed (CNMD) Tops Q1 EPS by 6c, Raises Guidance

Conmed (NYSE: CNMD) reported Q1 EPS of $0.66, $0.06 better than the analyst estimate of $0.60. Revenue for the quarter came in at $295.5 million versus the consensus estimate of $266.67 million.

GUIDANCE:

Conmed sees FY2023 revenue of $1.21-1.25 billion, versus the consensus of $1.19 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
• CONMED names John Gallagher as CFO, effective July 2026